Arax Advisory Partners’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$75.5K Buy
11,705
+11,387
+3,581% +$75.4K ﹤0.01% 2947
2026
Q1
$2.02K Buy
318
+212
+200% +$1.31K ﹤0.01% 3105
2025
Q4
$713 Sell
106
-1,743
-94% -$13.1K ﹤0.01% 3548
2025
Q3
$15.1K Buy
+1,849
New +$13.8K ﹤0.01% 2409
2025
Q2
Sell
-1,837
Closed -$13.1K 3127
2025
Q1
$13.1K Buy
+1,837
New +$17.3K ﹤0.01% 1479
2024
Q4
Sell
-1,187
Closed -$11.5K 2572
2024
Q3
$11.5K Hold
1,187
﹤0.01% 1345
2024
Q2
$9.65K Buy
+1,187
New +$9.19K ﹤0.01% 1282

Other funds holding INGN

Arax Advisory Partners's INGN Position: Q2 2026 in Review

Arax Advisory Partners increased its Inogen (INGN) stake by 3,581% in Q2 2026, buying an estimated $75.4K and bringing the position to 11,705 shares worth $75.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2947.

Arax Advisory Partners first reported a position in INGN in Q2 2024 and has held it in 7 quarters since. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • Arax Advisory Partners held 11,705 shares of Inogen worth $75.5K as of Q2 2026.
  • Arax Advisory Partners bought 11,387 Inogen shares in Q2 2026, an estimated $75.4K.
  • Inogen made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2947 holding.
  • Arax Advisory Partners first reported a position in Inogen in Q2 2024 and has held it in 7 quarters since.
  • 129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.